financetom
Business
financetom
/
Business
/
Myriad Genetics Insider Sold Shares Worth $400,800, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Myriad Genetics Insider Sold Shares Worth $400,800, According to a Recent SEC Filing
Sep 13, 2024 1:34 PM

04:21 PM EDT, 09/12/2024 (MT Newswires) -- Paul J Diaz, Director, President and CEO, on September 11, 2024, sold 15,000 shares in Myriad Genetics ( MYGN ) for $400,800. Following the Form 4 filing with the SEC, Diaz has control over a total of 977,378 shares of the company, with 977,378 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/899923/000162828024040232/xslF345X05/wk-form4_1726171896.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Advanced Drainage Systems Keeps Quarterly Dividend Steady at $0.16 per Share, Payable Dec. 16 to Shareholders of Record on Dec. 2
--Advanced Drainage Systems Keeps Quarterly Dividend Steady at $0.16 per Share, Payable Dec. 16 to Shareholders of Record on Dec. 2
Nov 9, 2024
10:28 AM EST, 11/08/2024 (MT Newswires) -- Price: 143.06, Change: -15.95, Percent Change: -10.03 ...
Cloudflare Unusual Options Activity For November 08
Cloudflare Unusual Options Activity For November 08
Nov 9, 2024
Deep-pocketed investors have adopted a bearish approach towards Cloudflare ( NET ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in NET usually suggests something big is about to happen. We gleaned this information from...
-- Medicenna Brief: Presenting Preclinical Data from its Anti-PD1-IL-2 BiSKIT and IL-2 Super Agonist Programs at 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
-- Medicenna Brief: Presenting Preclinical Data from its Anti-PD1-IL-2 BiSKIT and IL-2 Super Agonist Programs at 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Nov 9, 2024
10:00 AM EST, 11/08/2024 (MT Newswires) -- Price: 2.30, Change: -0.17, Percent Change: -6.88 ...
Huron Consulting Group Insider Sold Shares Worth $256,846, According to a Recent SEC Filing
Huron Consulting Group Insider Sold Shares Worth $256,846, According to a Recent SEC Filing
Nov 9, 2024
10:01 AM EST, 11/08/2024 (MT Newswires) -- James H Roth, Director, on November 06, 2024, sold 2,000 shares in Huron Consulting Group ( HURN ) for $256,846. Following the Form 4 filing with the SEC, Roth has control over a total of 54,825 shares of the company, with 54,825 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1289848/000128984824000214/xslF345X05/wk-form4_1731075168.xml Price: 128.12, Change: +0.46, Percent...
Copyright 2023-2026 - www.financetom.com All Rights Reserved